Table 2 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors
Meredith McKean, Vicky Barnhart, Eric Tu, Raymond Mager et al.
Topics
Monoclonal and Polyclonal Antibodies Research
article
Table 2 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors
Meredith McKean, Vicky Barnhart, Eric Tu, Raymond Mager, Martina Imbimbo, Chunling Fan, Carine Paturel, Yun He, Steven Eck, Paula G. Fraenkel, Antoîne Italiano, Elina Murtomaki, Benedito A. Carneiro, Zachary A. Cooper, Patricia Martín-Romano, Teresa Macarulla, Antoine Hollebecque, John D. Powderly, Arsène‐Bienvenu Loembé, Eduardo Castañón Álvarez, Agnes Boyer Chamard